Prescription for Better Access
Inside the Cost Curve: An Interview with Brian Reid
<p>In this episode, we interview Brian Reid, the founder of Reid Strategic and the creator and editor of our favorite industry newsletter, the Cost Curve. Brian shares his journey to create the Cost Curve and how he navigates the onslaught of information to identify the most important issues of the day. We also get his take on what he calls the highest “importance-to-attention” healthcare stories, highlighting critical topics that are undercovered related to their significance. We also get the opportunity to understand his perspectives on the threats to innovation, the risks to patient affordability programs, and what all of us should be doing to be better healthcare consumers.</p>
- Brian Reid- Reid Strategic
- Cost Curve Newsletter
- Martin Shkreli & Daraprim
- BioPharma Dive: Biotech and Pharma Industry News
- GLP-1s
- Net Price– “a drug’s net price equals the actual revenues that a manufacturer earns from a drug after rebates, discounts, and other reductions” Source: Drug Channels
- Armamentarium
- Pharmacy Benefit Managers (PBMs)
- Mark Cuban Pharmacy
- Psuedo-Generic Medication
- CVS Cordavis
- Quallent
- Nuvalia
- Biosimilars
- Lilly Direct
- Novo
-
340B Drug Pricing Program
- Copay maximizers
- AFPs
Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.